Latest filings (excl ownership)
REVOKED
Registration or securities revoked
4 Dec 12
NT 10-K
Notice of late annual filing
31 Mar 11
RW
Registration withdrawal request
31 Jan 11
8-K
Departure of Directors or Certain Officers
10 Dec 10
10-Q
2010 Q3
Quarterly report
22 Nov 10
NT 10-Q
Notice of late quarterly filing
16 Nov 10
S-1/A
IPO registration (amended)
4 Nov 10
DEF 14A
Definitive proxy
7 Sep 10
PRER14A
Preliminary revised proxy
27 Aug 10
PRE 14A
Preliminary proxy
20 Aug 10
10-Q
2010 Q2
Quarterly report
16 Aug 10
S-1/A
IPO registration (amended)
3 Aug 10
8-K
Entry into a Material Definitive Agreement
2 Jul 10
S-1
IPO registration
9 Jun 10
8-K
Amendments to Articles of Incorporation or Bylaws
25 May 10
10-Q
2010 Q1
Quarterly report
21 May 10
NT 10-Q
Notice of late quarterly filing
17 May 10
8-K
Entry into a Material Definitive Agreement
4 May 10
8-K
Entry into a Material Definitive Agreement
12 Apr 10
10-K
2009 FY
Annual report
30 Mar 10
8-K
Departure of Directors or Certain Officers
4 Mar 10
DEF 14C
Information statement
22 Feb 10
PRE 14C
Preliminary information
11 Feb 10
D
$1.5M in debt / options, sold $900K, 9 investors
5 Feb 10
8-K
Entry into a Material Definitive Agreement
26 Jan 10
8-K
Entry into a Material Definitive Agreement
23 Dec 09
8-K
Departure of Directors or Certain Officers
7 Dec 09
UPLOAD
Letter from SEC
3 Dec 09
10-Q
2009 Q3
Quarterly report
19 Nov 09
NT 10-Q
Notice of late quarterly filing
17 Nov 09
8-K
Departure of Directors or Certain Officers
12 Nov 09
CORRESP
Correspondence with SEC
29 Oct 09
8-K
China Yongxin Pharmaceuticals Inc. Announces Second
20 Oct 09
UPLOAD
Letter from SEC
20 Oct 09
D
$1M in equity / options, sold $467.37K, 156 investors
13 Oct 09
8-K
Unregistered Sales of Equity Securities
30 Sep 09
10-Q
2009 Q2
Quarterly report
14 Aug 09
10-Q
2009 Q1
Quarterly report
15 May 09
10-K
2008 FY
Annual report
15 Apr 09
Latest ownership filings